Physiological myocardial hypertrophy: how and why?

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Frontiers in Bioscience

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.2741/2681PMID 17981549
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Insulin signalling to mTOR mediated by the Akt/PKB substrate PRAS40

  2007cited by this paper
• Protective effects of exercise and phosphoinositide 3-kinase(p110α) signaling in dilated and hypertrophic cardiomyopathy

  2007cited by this paper
• Cardiac-specific overexpression of E40K active Akt prevents pressure overload-induced heart failure in mice by increasing angiogenesis and reducing apoptosis

  2007cited by this paper
• Vascular Endothelial Growth Factor Blockade Promotes the Transition From Compensatory Cardiac Hypertrophy to Failure in Response to Pressure Overload

  2006cited by this paper
• The myocardin family of transcriptional coactivators: versatile regulators of cell growth, migration, and myogenesis.

  2006cited by this paper
• Exercise Can Prevent and Reverse the Severity of Hypertrophic Cardiomyopathy

  2006cited by this paper
• Interaction of FoxO1 and TSC2 Induces Insulin Resistance through Activation of the Mammalian Target of Rapamycin/p70 S6K Pathway*

  2006cited by this paper
• Akt1 Is Required for Physiological Cardiac Growth

  2006cited by this paper
• Activation of the Cardiac Proteasome During Pressure Overload Promotes Ventricular Hypertrophy

  2006cited by this paper
• Vascular endothelial growth factor delays onset of failure in pressure–overload hypertrophy through matrix metalloproteinase activation and angiogenesis

  2006cited by this paper
• Akt signaling and growth of the heart.

  2006influential reference
• Insulin-like growth factor-1 and PTEN deletion enhance cardiac L-type Ca2+ currents via increased PI3Kalpha/PKB signaling.

  2006cited by this paper
• Effects of Akt on cardiac myocytes: location counts.

  2006cited by this paper
• Ribosomal protein S6 phosphorylation: from protein synthesis to cell size.

  2006cited by this paper
• eIF2 and the control of cell physiology.

  2005cited by this paper
• PDK2: the missing piece in the receptor tyrosine kinase signaling pathway puzzle.

  2005cited by this paper
• Dosage-dependent effects of Akt1/protein kinase Balpha (PKBalpha) and Akt3/PKBgamma on thymus, skin, and cardiovascular and nervous system development in mice.

  2005cited by this paper
• The FOXO3a Transcription Factor Regulates Cardiac Myocyte Size Downstream of AKT Signaling*

  2005cited by this paper
• Nuclear Targeting of Akt Enhances Ventricular Function and Myocyte Contractility

  2005cited by this paper
• PHLPP: a phosphatase that directly dephosphorylates Akt, promotes apoptosis, and suppresses tumor growth.

  2005cited by this paper
• Role for Akt3/protein kinase Bgamma in attainment of normal brain size.

  2005cited by this paper
• Molecular and Functional Signature of Heart Hypertrophy During Pregnancy

  2005cited by this paper
• Resistance Exercise Increases Muscle Protein Synthesis and Translation of Eukaryotic Initiation Factor 2Bϵ mRNA in a Mammalian Target of Rapamycin-dependent Manner*

  2005cited by this paper
• Phosphorylation and Regulation of Akt/PKB by the Rictor-mTOR Complex

  2005cited by this paper
• Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure.

  2005cited by this paper
• Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy.

  2004cited by this paper
• Phosphoinositide 3-kinase gamma: kinase-dependent and -independent activities in cardiovascular function and disease.

  2004cited by this paper
• Deletion of Ribosomal S6 Kinases Does Not Attenuate Pathological, Physiological, or Insulin-Like Growth Factor 1 Receptor-Phosphoinositide 3-Kinase-Induced Cardiac Hypertrophy

  2004cited by this paper
• Atrogin-1/muscle atrophy F-box inhibits calcineurin-dependent cardiac hypertrophy by participating in an SCF ubiquitin ligase complex.

  2004cited by this paper
• Aerobic Fitness Is Associated With Cardiomyocyte Contractile Capacity and Endothelial Function in Exercise Training and Detraining

  2004cited by this paper
• Inhibition of mTOR Signaling With Rapamycin Regresses Established Cardiac Hypertrophy Induced by Pressure Overload

  2004cited by this paper
• Deletion of Ribosomal S 6 Kinases Does Not Attenuate Pathological , Physiological , or Insulin-Like Growth Factor 1 Receptor – Phosphoinositide 3-Kinase-Induced Cardiac Hypertrophy

  2004cited by this paper
• The insulin-like growth factor 1 receptor induces physiological heart growth via the phosphoinositide 3-kinase(p110alpha) pathway.

  2004cited by this paper
• Muscle-specific RING finger 1 is a bona fide ubiquitin ligase that degrades cardiac troponin I

  2004cited by this paper
• Rapamycin Attenuates Load-Induced Cardiac Hypertrophy in Mice

  2003cited by this paper
• Nuclear Targeting of Akt Enhances Kinase Activity and Survival of Cardiomyocytes

  2003cited by this paper
• Sizing up the heart: development redux in disease.

  2003cited by this paper
• Atrophic Remodeling of the Heart In Vivo Simultaneously Activates Pathways of Protein Synthesis and Degradation

  2003cited by this paper
• Dwarfism, impaired skin development, skeletal muscle atrophy, delayed bone development, and impeded adipogenesis in mice lacking Akt1 and Akt2.

  2003cited by this paper
• Minimally invasive aortic banding in mice: effects of altered cardiomyocyte insulin signaling during pressure overload.

  2003cited by this paper
• Deficiency of PDK1 in cardiac muscle results in heart failure and increased sensitivity to hypoxia

  2003cited by this paper
• GSK-3: tricks of the trade for a multi-tasking kinase

  2003cited by this paper
• Mechanism of Enhanced Cardiac Function in Mice with Hypertrophy Induced by Overexpressed Akt*

  2003cited by this paper
• Phosphoinositide 3-kinase(p110α) plays a critical role for the induction of physiological, but not pathological, cardiac hypertrophy

  2003cited by this paper
• Insulin-Like Growth Factor-1 Exerts Ca2+-Dependent Positive Inotropic Effects in Failing Human Myocardium

  2003cited by this paper
• Cardiac hypertrophy: the good, the bad, and the ugly.

  2003cited by this paper
• Concentric versus eccentric remodeling.

  2002cited by this paper
• Insulin signaling coordinately regulates cardiac size, metabolism, and contractile protein isoform expression.

  2002cited by this paper
• Glycogen synthase kinase-3beta: a novel regulator of cardiac hypertrophy and development.

  2002cited by this paper
• Cardiac-Specific IGF-1 Expression Attenuates Dilated Cardiomyopathy in Tropomodulin-Overexpressing Transgenic Mice

  2002cited by this paper
• Conditional switching of VEGF provides new insights into adult neovascularization and pro‐angiogenic therapy

  2002cited by this paper
• Aerobic exercise reduces cardiomyocyte hypertrophy and increases contractility, Ca2+ sensitivity and SERCA-2 in rat after myocardial infarction.

  2002cited by this paper
• Cardiomyocyte cell cycle regulation.

  2002cited by this paper
• Regulation of myocardial contractility and cell size by distinct PI3K-PTEN signaling pathways.

  2002cited by this paper
• Phenotypic Spectrum Caused by Transgenic Overexpression of Activated Akt in the Heart*

  2002cited by this paper
• Structural and functional changes in left ventricle during normotensive and preeclamptic pregnancy.

  2002cited by this paper
• Akt Signaling Mediates Postnatal Heart Growth in Response to Insulin and Nutritional Status*

  2002cited by this paper
• Akt/Protein Kinase B Promotes Organ Growth in Transgenic Mice

  2002cited by this paper
• Akt induces enhanced myocardial contractility and cell size in vivo in transgenic mice

  2002cited by this paper
• Activated glycogen synthase-3 beta suppresses cardiac hypertrophy in vivo.

  2002cited by this paper
• Akt1/PKBα Is Required for Normal Growth but Dispensable for Maintenance of Glucose Homeostasis in Mice*

  2001cited by this paper
• Reperfusion-Activated Akt Kinase Prevents Apoptosis in Transgenic Mouse Hearts Overexpressing Insulin-Like Growth Factor-1

  2001cited by this paper
• Cytoplasmic signaling pathways that regulate cardiac hypertrophy.

  2001cited by this paper
• Growth retardation and increased apoptosis in mice with homozygous disruption of the Akt1 gene.

  2001cited by this paper
• Myocyte-enriched calcineurin-interacting protein, MCIP1, inhibits cardiac hypertrophy in vivo

  2001cited by this paper
• Increased Cardiac Sympathetic Activity and Insulin-Like Growth Factor-I Formation Are Associated With Physiological Hypertrophy in Athletes

  2001cited by this paper
• The conserved phosphoinositide 3‐kinase pathway determines heart size in mice

  2000cited by this paper
• Pulmonary vascular disease and pregnancy: current controversies, management strategies, and perspectives.

  2000cited by this paper
• The beta(2)-adrenergic receptor delivers an antiapoptotic signal to cardiac myocytes through G(i)-dependent coupling to phosphatidylinositol 3'-kinase.

  2000cited by this paper
• Insulin-like growth factor I as a cardiac hormone: physiological and pathophysiological implications in heart disease.

  1999cited by this paper
• Why is left ventricular hypertrophy so predictive of morbidity and mortality?

  1999cited by this paper
• Adrenergic and muscarinic receptors in the human heart.

  1999cited by this paper
• Low- and high-level transgenic expression of beta2-adrenergic receptors differentially affect cardiac hypertrophy and function in Galphaq-overexpressing mice.

  1999cited by this paper
• Insulin-like growth factor-1 attenuates the detrimental impact of nonocclusive coronary artery constriction on the heart.

  1999cited by this paper
• Mechanisms of cardiac hypertrophy in canine volume overload.

  1998cited by this paper
• Pathological versus physiological left ventricular hypertrophy: a review.

  1998cited by this paper
• Phosphoinositide 3-kinases: a conserved family of signal transducers.

  1997cited by this paper
• Adenylyl cyclase and G protein receptor kinase expression during development of heart failure.

  1997cited by this paper
• Cardiovascular and metabolic effects of insulin-like growth factor I at rest and during exercise in humans.

  1996cited by this paper
• The catalytic subunit of protein phosphatase 2A associates with the translation termination factor eRF1.

  1996cited by this paper
• Control mechanisms for physiological hypertrophy of pregnancy.

  1996cited by this paper
• Postnatal growth of the heart and its blood vessels.

  1996influential reference
• Rapamycin selectively inhibits angiotensin II-induced increase in protein synthesis in cardiac myocytes in vitro. Potential role of 70-kD S6 kinase in angiotensin II-induced cardiac hypertrophy.

  1995cited by this paper
• Angiotensin II partly mediates mechanical stress-induced cardiac hypertrophy.

  1995cited by this paper
• Insulin-like growth factor-1 enhances ventricular hypertrophy and function during the onset of experimental cardiac failure.

  1995cited by this paper
• Cardiac function in mice overexpressing the beta-adrenergic receptor kinase or a beta ARK inhibitor.

  1995cited by this paper
• Structural basis for heart failure. Ventricular remodeling and its pharmacological inhibition.

  1995cited by this paper
• Acute changes in myosin heavy chain synthesis rate in pressure versus volume overload.

  1994cited by this paper
• The athletic heart.

  1993cited by this paper
• Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro.

  1993cited by this paper
• Beta-adrenoceptors in cardiac disease.

  1993cited by this paper
• The earliest Acheulean from Konso-Gardula

  1993cited by this paper
• Left ventricular diastolic and systolic performance during chronic experimental aortic regurgitation.

  1992cited by this paper
• Angiogenesis in skeletal and cardiac muscle.

  1992cited by this paper
• Cardiac Hypertrophy: Mechanical, Neural, and Endocrine Dependence

  1991cited by this paper
• Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study.

  1990cited by this paper
• Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study.

  1990cited by this paper
• Chronic swimming reverses cardiac dysfunction and myosin abnormalities in hypertensive rats.

  1986cited by this paper
• Sympathetic nervous activity during exercise.

  1983cited by this paper
• The "athletic heart". Prevalence and physiological significance of left ventricular enlargement in distance runners.

  1976cited by this paper

• ALDH2 mediates the effects of sodium-glucose cotransporter 2 inhibitors (SGLT2i) on improving cardiac remodeling

  2024cites this paper
• 25-Hydroxycholecalciferol Improves Cardiac Metabolic Adaption, Mitochondrial Biogenetics, and Redox Status to Ameliorate Pathological Remodeling and Functional Failure in Obese Chickens

  2024cites this paper
• Fibroblast growth factor 18 alleviates stress-induced pathological cardiac hypertrophy in male mice

  2023cites this paper
• Androgen Receptor and Cardiovascular Disease: A Potential Risk for the Abuse of Supplements Containing Selective Androgen Receptor Modulators

  2023cites this paper
• Na+/H+ Exchanger 1, a Potential Therapeutic Drug Target for Cardiac Hypertrophy and Heart Failure

  2022cites this paper
• Identification of metabolic pathways underlying FGF1 and CHIR99021-mediated cardioprotection

  2022cites this paper
• The negative regulation of gene expression by microRNAs as key driver of inducers and repressors of cardiomyocyte differentiation

  2022cites this paper
• The insulin receptor family and protein kinase B (Akt) are activated in the heart by alkaline pH and α1-adrenergic receptors

  2021cites this paper
• CXCR7 ameliorates myocardial infarction as a β-arrestin-biased receptor

  2021cites this paper
• CXCR7 ameliorates myocardial infarction as a β-arrestin-biased receptor

  2021cites this paper
• Polycystin-1 is required for insulin-like growth factor 1-induced cardiomyocyte hypertrophy

  2021cites this paper
• Left ventricular hypertrophy is associated with overexpression of HSP60, TLR2, and TLR4 in the myocardium

  2020cites this paper
• Interactions between structural remodeling and volumetric growth in right ventricle in response to pulmonary arterial hypertension.

  2019cites this paper
• ER Protein Quality Control and the Unfolded Protein Response in the Heart.

  2018cites this paper
• Studies of the role of MAP kinase-activated protein kinase-5 (MK5) in reactive and reparative fibrosis in the murine heart

  2018cites this paper
• A new miRNA regulator, miR-672, reduces cardiac hypertrophy by inhibiting JUN expression.

  2018cites this paper
• PH domain leucine-rich repeat protein phosphatase 2 (PHLPP2) regulates G-protein–coupled receptor kinase 5 (GRK5)-induced cardiac hypertrophy in vitro

  2018cites this paper
• Impact of exercise early in life on the adult heart

  2017cites this paper
• Obesity‐associated cardiac pathogenesis in broiler breeder hens: Pathological adaption of cardiac hypertrophy1,2

  2017cites this paper
• Characterization Of Pregnancy Induced Cardiac Hypertrophy In Rats

  2017cites this paper
• PHLPP2 Negatively Regulates Phenylephrine (PE)- induced Cardiac Hypertrophy

  2017cites this paper
• Basic Signaling in Cardiac Fibroblasts

  2017cites this paper
• Obesity‐associated cardiac pathogenesis in broiler breeder hens: Development of metabolic cardiomyopathy2,3

  2017cites this paper
• Cardiac hypertrophy and IGF-1 response to testosterone propionate treatment in trained male rats

  2017cites this paper
• Effect of exercise training and myocardial infarction on force development and contractile kinetics in isolated canine myocardium.

  2016cites this paper
• Extracellular matrix-mediated cellular communication in the heart.

  2016cites this paper
• The TIR/BB-loop mimetic AS-1 attenuates mechanical stress-induced cardiac fibroblast activation and paracrine secretion via modulation of large tumor suppressor kinase 1.

  2016cites this paper
• Loss of Mouse P2Y6 Nucleotide Receptor Is Associated with Physiological Macrocardia and Amplified Pathological Cardiac Hypertrophy*

  2016cites this paper
• Moderate ethanol administration accentuates cardiomyocyte contractile dysfunction and mitochondrial injury in high fat diet-induced obesity.

  2015cites this paper
• Pik3ip1 Modulates Cardiac Hypertrophy by Inhibiting PI3K Pathway

  2015cites this paper
• Cardiac fibroblast physiology and pathology.

  2015cites this paper
• The role of TGFβ1 and LRG1 in cardiac remodelling and heart failure

  2015cites this paper
• The Multiple Actions of the Insulin-Like Growth Factor-I Signaling in the Myocardium

  2015cites this paper
• UNIVERSITY OF CALIFORNIA, SAN DIEGO Effects of PHLPP1 Removal in the Heart A Thesis submitted in partial satisfaction of the requirements for the degree Master of Science in Biology By Courtney Moc Committee in charge:

  2015cites this paper
• Effects of miRNA-455 on cardiac hypertrophy induced by pressure overload

  2015cites this paper
• Physiological activation of Akt by PHLPP1 deletion protects against pathological hypertrophy.

  2015cites this paper
• Current Concepts in the Role of Mechanosensing in the Regulation of Cardiac Contractile Function

  2015cites this paper
• The role of TGFβ1 and LRG1 in cardiac remodelling and heart failure

  2015cites this paper
• Mechanosensing and Regulation of Cardiac Function

  2014cites this paper
• Differential and Conditional Activation of PKC-Isoforms Dictates Cardiac Adaptation during Physiological to Pathological Hypertrophy

  2014cites this paper
• Redox regulation of cardiac hypertrophy.

  2014cites this paper
• Role of Heterotrimeric G Protein and Calcium in Cardiomyocyte Hypertrophy Induced by IGF‐1

  2014influential citation
• ERBB2 Deficiency Alters an E2F-1-Dependent Adaptive Stress Response and Leads to Cardiac Dysfunction

  2014cites this paper
• The transcription factor FOXM1 (Forkhead box M1): proliferation-specific expression, transcription factor function, target genes, mouse models, and normal biological roles.

  2013cites this paper
• Animal behavior: shifting neural circuits with sex hormones.

  2013cites this paper
• Neuronal nitric oxide synthase is indispensable for the cardiac adaptive effects of exercise

  2013cites this paper
• From tissue mechanics to transcription factors.

  2013cites this paper
• Gene Network and Proteomic Analyses of Cardiac Responses to Pathological and Physiological Stress

  2013cites this paper
• THE INDISPENSIBLE MISSION OF miRNA IN HUMAN DISORDERS

  2013cites this paper
• Cardiovascular biology: play it again, Gata4.

  2013cites this paper
• HEXIM1: a new player in myocardial hypertrophy?

  2013cites this paper
• The Role Of Homeodomain Transcription Factor Irx5 In Cardiac Contractility and Hypertrophic Response

  2012cites this paper
• Role of GPCR signaling in cardiac progenitor cells

  2012cites this paper
• IGF-1 Response to Arm Exercise with Eccentric and Concentric Muscle Contractions in Resistance-Trained Athletes with Left Ventricular Hypertrophy

  2012cites this paper
• The adult heart responds to increased workload with physiologic hypertrophy, cardiac stem cell activation, and new myocyte formation

  2012cites this paper
• The aging myostatin null phenotype: reduced adiposity, cardiac hypertrophy, enhanced cardiac stress response, and sexual dimorphism.

  2012cites this paper
• Normal lactational environment restores cardiomyocyte number after uteroplacental insufficiency: implications for the preterm neonate.

  2012cites this paper
• Cell lineages, growth and repair of the mouse heart.

  2012cites this paper
• Insulin-Like Growth Factor 1 Alleviates High-Fat Diet–Induced Myocardial Contractile Dysfunction: Role of Insulin Signaling and Mitochondrial Function

  2012cites this paper
• Role of the Actin Cytoskeleton in Pro-fibrotic Signaling

  2012cites this paper
• MicroRNAs Telltale Effects on Signaling Networks in Cardiomyopathy

  2012cites this paper
• Scaffolding protein Homer 1c mediates hypertrophic responses downstream of Gq in cardiomyocytes

  2012cites this paper
• Deep RNA Sequencing Reveals Novel Cardiac Transcriptomic Signatures for Physiological and Pathological Hypertrophy

  2012cites this paper
• Neuronal Nitric Oxide Synthase Signaling Contributes to the Beneficial Cardiac Effects of Exercise

  2012cites this paper
• Early activation of intracellular signals after myocardial stretch: Anrep effect, myocardial hypertrophy and heart failure

  2012cites this paper
• Characterization Of Pregnancy Induced Cardiac Hypertrophy In Rats

  2011cites this paper
• Cardiac Overexpression of Insulin-Like Growth Factor I (IGF-1) Attenuates Chronic Alcohol Intake-Induced Myocardial Contractile Dysfunction But Not Hypertrophy: Role of Akt, mTOR, GSK3 β and PTEN

  2011cites this paper
• Heart Failure 1 In search of new therapeutic targets and strategies for heart failure : recent advances in basic science

  2011cites this paper
• Endocrine actions of myostatin: systemic regulation of the IGF and IGF binding protein axis.

  2011cites this paper
• ventricular myocytes norepinephrine-induced hypertrophy of neonatal rat -estradiol in β -dihydrotestosterone or 17 α Signaling responses after exposure to 5

  2011cites this paper
• Is the ‘Athlete’s Heart’ Arrhythmogenic?

  2011cites this paper
• Redox signaling in cardiac myocytes

  2011cites this paper
• In vivo key role of reactive oxygen species and NHE-1 activation in determining excessive cardiac hypertrophy

  2011cites this paper
• Mechanical induction of gene expression in connective tissue cells.

  2010cites this paper
• The Role of MicroRNAs in Human Diseases

  2010cites this paper
• MicroRNAs target gene and signaling pathway by bioinformatics analysis in the cardiac hypertrophy.

  2010cites this paper
• Potential treatment of cardiac hypertrophy and heart failure by inhibiting the sarcolemmal binding of phospholipase Cbeta1b.

  2010cites this paper
• NADPH oxidase-4 mediates protection against chronic load-induced stress in mouse hearts by enhancing angiogenesis

  2010cites this paper
• Genome-wide expression patterns in physiological cardiac hypertrophy

  2010cites this paper
• High AU content: a signature of upregulated miRNA in cardiac diseases

  2010cites this paper
• Temporal alterations in cardiac fibroblast function following induction of pressure overload

  2010cites this paper
• A distinct AMP‐activated protein kinase phosphorylation site characterizes cardiac hypertrophy induced by l‐thyroxine and angiotensin II

  2010cites this paper
• Signaling responses after exposure to 5-dihydrotestosterone or 17-estradiol in norepinephrine-induced hypertrophy of neonatal rat ventricular myocytes

  2010cites this paper
• Mechanical Stretch-Induced Reorganization of the Cytoskeleton and the Small GTPase Rac-1 in Cardiac Fibroblasts

  2010cites this paper
• Signaling responses after exposure to 5 alpha-dihydrotestosterone or 17 beta-estradiol in norepinephrine-induced hypertrophy of neonatal rat ventricular myocytes.

  2010cites this paper
• Cardiac overexpression of insulin-like growth factor 1 attenuates chronic alcohol intake-induced myocardial contractile dysfunction but not hypertrophy: Roles of Akt, mTOR, GSK3beta, and PTEN.

  2010cites this paper
• norepinephrine-induced hypertrophy of neonatal rat ventricular myocytes 3

  2009cites this paper
• The transcription factor Eya2 prevents pressure overload-induced adverse cardiac remodeling.

  2009cites this paper
• Advances in Molecular Genetics , Genomics , Proteomics , Metabolomics , and Systems Biology MicroRNAs in Cardiovascular Biology and Heart Disease

  2009cites this paper
• S6 kinase 1 knockout inhibits uninephrectomy- or diabetes-induced renal hypertrophy.

  2009cites this paper
• Transcriptional profile of isoproterenol-induced cardiomyopathy and comparison to exercise-induced cardiac hypertrophy and human cardiac failure

  2009cites this paper
• Cardiac Fibroblast: The Renaissance Cell

  2009cites this paper
• MYOSTATIN NEGATIVELY REGULATES CARDIAC MUSCLE GROWTH , DEVELOPMENT AND PERFORMANCE By

  2009influential citation
• Akt Increases Sarcoplasmic Reticulum Ca2+ Cycling by Direct Phosphorylation of Phospholamban at Thr17*

  2009cites this paper
• Innovative molekulare Therapiestrategien in der Kardiologie

  2009cites this paper
• Serum IGF-I and hormonal responses to incremental exercise in athletes with and without left ventricular hypertrophy.

  2009cites this paper
• Polymorphisms in the IGF1 signalling pathway including the myostatin gene are associated with left ventricular mass in male athletes

  2009cites this paper
• Intervals, Thresholds, and Long Slow Distance: the Role of Intensity and Duration in Endurance Training

  2009cites this paper
• MicroRNAs in Cardiovascular Biology and Heart Disease

  2009cites this paper
• Early exercise training after myocardial infarction prevents contractile but not electrical remodelling or hypertrophy.

  2009cites this paper